Surge Components (Surge Components) Risk Assessment

View and export this data going back to 1996. Start your Free Trial

What is Surge Components Risk Assessment?

Risk Assessment represents the investment risk of a stock derived from our exclusive method. It suggests how risky the investment opportunity is based on the valuation and the fundamental performance of the stock. It is derived from following key aspects:

1. GuruFocus internally developed valuations of the stock, such as GF valuation.
2. Quality Rank, a business quality indicator developed by GuruFocus.
3. Fundamental performance: Piotroski F-Score, Altman Z-Score, Beneish M-Score, etc.
4. Growth opportunities: 5-year revenue growth rate, 5-Year EPS without NRI Growth Rate, etc.

Value investors are always willing to find undervalued stocks. However, not all the undervalued stocks are good deals, we should also be careful of how risky the investment opportunity is. We believe that if the company's financial strength and profitability are strong, and the stock price is within a reasonable range of the GF valuation, or stock has a high return with its price being undervalued, then it might be a good investment opportunity with low risk.

Based on those aspects listed above, GuruFocus believes the risk assessment of Surge Components is: Low Risk: Strong fundamentals, worth long-term holding.

Competitive Comparison of Surge Components's Risk Assessment

For the Electronics & Computer Distribution subindustry, Surge Components's Risk Assessment, along with its competitors' market caps and Risk Assessment data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Surge Components's Risk Assessment Distribution in the Hardware Industry

For the Hardware industry and Technology sector, Surge Components's Risk Assessment distribution charts can be found below:

* The bar in red indicates where Surge Components's Risk Assessment falls into.

Surge Components (OTCPK:SPRS) Risk Assessment Explanation

Based on the four aspects listed above, GuruFocus provides the following 7 evaluations:

All-in-One Screener Examples (1)
Low Risk: Strong fundamentals, worth long-term holding
Moderate Risk: Sensitive, better choose undervalued stock
High Risk: High uncertainty with risk-return tradeoff
High Risk: Good fundamentals, beware of shrinking business
High Risk: Sensitive to economic or industry trends
High Risk: High uncertainty
No Data: Cannot be evaluated

(1) These are some simple examples. You can access our Risk Assessment filter under All-in-One Screener’s Fundamental tab and set your own criteria.

Surge Components Risk Assessment Related Terms

Thank you for viewing the detailed overview of Surge Components's Risk Assessment provided by GuruFocus.com. Please click on the following links to see related term pages.

Surge Components (Surge Components) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Technology » Hardware » Surge Components Inc (OTCPK:SPRS) » Definitions » Risk Assessment

Comparable Companies

Traded in Other Exchanges

N/A

Address

95 East Jefryn Boulevard, Deer Park, New York, NY, USA, 11729

Website

https://www.surgecomponents.com

Surge Components Inc is a supplier of electronic products and components. The company's products include capacitors, which are electrical energy storage devices, and discrete components, such as rectifiers, transistors, and diodes. Its marketed products are utilized in the electronic circuitry of products, comprising of automobiles, telecom, audio, cellular telephones, computers, consumer electronics, garage door openers, household appliances, power supplies and security equipment. In addition, the company's products are also sold to original equipment manufacturers and distributors.

Executives

Peter Levy	director	C/O ATLAS THERAPEUTICS CORPORATION, 4640 ADMIRALTY WAY, SUITE 500, MARINA DEL REY CA 90292
Michael D Tofias	10 percent owner	325 NORTH END AVENUE, APT. 25B, NEW YORK NY 10282
Steven J Lubman	director, officer: VP, Secretary, Director	1016 GRAND BLVD, DEER PARK NY 11729
Martin Novick	director
Alan Plafker	director	24 SYLVIA ROAD, PLAINVIEW NY 11803
Gary Mark Jacobs	director	15 HOOVER STREET, INWOOD NY 11096
Lawrence Chariton	director	30 ROCKAWAY PLACE, MASSAPEQUA NY 11758
Ira Levy	director, officer: Chief Executive Officer
David Siegel	director	95 EAST JEFRYN BOULEVARD, DEER PARK NY 11729